STMN3
Stathmin-3
Also known as: SCLIP, STMN3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZ72
- Gene
- STMN3
- Ensembl
- ENSG00000197457
- Chromosome
- 20
- Canonical length
- 180 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene encodes a protein which is a member of the stathmin protein family. Members of this protein family form a complex with tubulins at a ratio of 2 tubulins for each stathmin protein. Microtubules require the ordered assembly of alpha- and beta-tubulins, and formation of a complex with stathmin disrupts microtubule formation and function. A pseudogene of this gene is located on chromosome 22. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
Canonical amino-acid sequenceUniProt
180 residues, UniProt reviewed canonical sequence.
>Q9NZ72|STMN3
1 MASTISAYKE KMKELSVLSL ICSCFYTQPH PNTVYQYGDM EVKQLDKRAS GQSFEVILKS
61 PSDLSPESPM LSSPPKKKDT SLEELQKRLE AAEERRKTQE AQVLKQLAER REHEREVLHK
121 ALEENNNFSR QAEEKLNYKM ELSKEIREAH LAALRERLRE KELHAAEVRR NKEQREEMSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STMN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 337 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 337 nTPM
- amygdala: 285 nTPM
- basal ganglia: 273 nTPM
- hippocampal formation: 265 nTPM
- cerebellum: 252 nTPM
- hypothalamus: 246 nTPM
Single-cell type
- other brain neurons: 120 nCPM
- retinal amacrine cells: 96 nCPM
- brain excitatory neurons: 91 nCPM
- brain inhibitory neurons: 90 nCPM
- granulosa cells: 76 nCPM
- retinal bipolar cells: 72 nCPM
Immune cell
- naive CD4 T-cell: 6.2 nTPM
- naive CD8 T-cell: 5.3 nTPM
- memory CD4 T-cell: 5.2 nTPM
- memory CD8 T-cell: 4.5 nTPM
- MAIT T-cell: 2.7 nTPM
- gdT-cell: 2.5 nTPM
Brain region
- pons: 545 nTPM
- cerebral cortex: 523 nTPM
- amygdala: 382 nTPM
- basal ganglia: 382 nTPM
- medulla oblongata: 378 nTPM
- hippocampal formation: 362 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 1.34
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blastocyst hatching
- cytoplasmic microtubule organization
- microtubule depolymerization
- negative regulation of neuron projection development
- negative regulation of Rac protein signal transduction
- nervous system development
- neuron projection development
- regulation of cytoskeleton organization
- regulation of microtubule polymerization or depolymerization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STMN3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STMN3 as an antibody target. Whether an autoantibody or antibody against STMN3 could matter depends on whether native STMN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STMN3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STMN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...